Optical Detection of Intravenous Infiltration:A Pilot Study

This study will examine the use of the ivWatch Model 400 to monitor PIV sites in pediatric patients. Half the participants will be monitored by the device without infiltration notifications and the other half will be monitored by the device with infiltration notifications enabled.

Inclusion Criteria:

• Signed consent and/or assent
• Newborn to 17 years of age
• Weight > 2.5 kg

Exclusion Criteria:

• Severe skin integrity issues such as severe eczema, burns, epidermolysis bullosa, rash, hives
• Severe scarring of tissue (excessive IV use)
• Tattoo in area of PIV site
• IV site located in antecubital fossa